Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group.
about
Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseMedical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseLong-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis.Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus.Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease.Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trialA systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders.A review of rabeprazole in the treatment of acid-related diseasesA randomized, double blinded, clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux diseaseGuidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus.Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease.Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects.A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages.Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression.Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease.
P2860
Q24240101-77EE1560-58A0-4DC5-B5CF-4AF16F142E5EQ24245681-28F8753A-3464-4C9F-85CE-4652E358597BQ30439352-EBD7B773-F7F6-4C65-B641-4ECEECC4E1BBQ35164691-57DB4A43-16AF-4888-8E43-8AC6105C62FFQ35216881-110BD468-C61A-459A-9212-ED046A9334BAQ35678985-BD4515E6-27F2-422E-9ADE-976A055708EFQ35745058-3C69107A-43C7-46DF-B591-466F81684822Q35923964-8B3B4377-F4F5-49F8-99A3-29F4EA42796CQ36661321-4B5665B0-1282-457E-8BB9-6B8969356C89Q36817415-938F6BDB-B6CC-4CEA-A5CF-B4E05CE71278Q37762466-71516887-FD01-443A-9325-1A4B9C90EEBFQ39405468-1C818F47-2C5F-40B4-8282-B420D49E183DQ39405474-28914D4B-1E83-4873-B096-6D672E4B05F7Q39422116-62250577-9E0B-4738-8E65-227875EC40DFQ44080548-E2207781-EF7A-48D0-9EB6-BFF2001E7DFBQ44299604-4D09D866-1BED-47BE-9585-B0BE3347656AQ44471231-8F5A4867-FB83-4213-85E8-6B30783DFD3DQ44700487-41014616-B132-4D8D-A244-EB33FCF3A98FQ46203790-33F15FD4-0B51-464D-A56A-83F5C1C6AD2F
P2860
Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Rabeprazole versus omeprazole ...... opean Rabeprazole Study Group.
@en
Rabeprazole versus omeprazole ...... opean Rabeprazole Study Group.
@nl
type
label
Rabeprazole versus omeprazole ...... opean Rabeprazole Study Group.
@en
Rabeprazole versus omeprazole ...... opean Rabeprazole Study Group.
@nl
prefLabel
Rabeprazole versus omeprazole ...... opean Rabeprazole Study Group.
@en
Rabeprazole versus omeprazole ...... opean Rabeprazole Study Group.
@nl
P2093
P356
P1476
Rabeprazole versus omeprazole ...... opean Rabeprazole Study Group.
@en
P2093
B Thjodleifsson
T Bjaaland
T J Humphries
V Finnegan
P2888
P304
P356
10.1023/A:1005548318996
P577
2000-05-01T00:00:00Z
P6179
1042959379